Labcorp Holdings Inc. (LH)
Healthcare
Diagnostics & Research
307.40 $
-0.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Labcorp Holdings Inc. (LH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 3,731 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3,057 | 3,033 | 3,177 | 3,221 | 3,282 | 3,329 | 3,345 | 3,527 | 3,564 | 3,516 | 3,538 | 3,731 | 14,348 | |
| 2,206 | 2,212 | 2,279 | 2,295 | 2,378 | 2,433 | 2,397 | 2,481 | 2,538 | 2,595 | 2,599 | 2,619 | 10,352 | |
| 851 | 821 | 897 | 926 | 904 | 896 | 948 | 1,046 | 1,025 | 921 | 938 | 1,112 | 3,996 | |
| – | 2.0 | – | – | – | – | – | – | – | – | – | – | – | |
| 526 | 533 | 508 | 558 | 569 | 595 | 546 | 579 | 552 | 539 | 551 | 577 | 2,219 | |
| 599 | 944 | 576 | 632 | 650 | 680 | 622 | 652 | 629 | 539 | 551 | 660 | 2,379 | |
| 252 | -123 | 321 | 295 | 254 | 217 | 326 | 395 | 397 | 382 | 387 | 452 | 1,617 | |
| 50 | 49 | 47 | 48 | 50 | 63 | 56 | 57 | 56 | 55 | 55 | 61 | 227 | |
| 239 | -147 | 297 | 268 | 211 | 184 | 275 | 305 | 337 | 191 | 320 | 386 | 1,234 | |
| 55 | 20 | 69 | 62 | 41 | 40 | 62 | 66 | 76 | 26 | 42 | 87 | 230 | |
| 183 | -167 | 228 | 205 | 169 | 143 | 213 | 238 | 261 | 165 | 278 | 299 | 1,002 | |
| 478 | 295 | 499 | 472 | 423 | 418 | 498 | 532 | 564 | 419 | 548 | 621 | 2,152 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.